Q1 2025 Hester Biosciences Ltd Earnings Call Transcript
Key Points
- Hester Biosciences Ltd (BOM:524669) reported a 35% quarter-on-quarter increase in sales for the Animal Healthcare Division.
- The Poultry Healthcare Division achieved a 35% growth in Q1, driven by vaccine sales and recovery in the poultry industry.
- The Petcare Division saw a 29% growth, significantly outpacing the market growth of 9%, driven by increased penetration among vet clinics.
- Hester Nepal generated positive cash flows and fully paid all bank term loans, despite a slight dip in turnover.
- The company reported a 30% increase in profit, with both EBITDA and PAT showing growth due to high-margin products and improved operational efficiency.
- Overall sales showed a 9% decrease due to a one-time pharmaceutical product sale in the previous year.
- Hester Africa ended the quarter with an overall loss of INR4.9 crores, primarily due to depreciation and unrealized foreign exchange fluctuations.
- The capacity utilization in Africa is currently only at 10%, indicating underutilization of resources.
- The company faces challenges in regulatory standards, which can delay the launch of new vaccines like the Lumpy Skin Disease vaccine in India.
- There is a dependency on external factors for the timely launch of new products, which can impact the company's growth trajectory.
Ladies and gentlemen, good day, and welcome to the Hester Biosciences Limited Q1 FY25 earnings conference call hosted by ICICI Securities Limited.
As a reminder, all participant lines will be in the listen-only mode and there will be an opportunity for you to ask questions after the presentation concludes. (Operator Instructions) Please note that it's being recorded. I now hand the conference over to Ms. Asha Shetty from ICICI Securities Limited. Thank you, and over to you, ma'am.
Thank you, Neha. Good afternoon, everyone. On behalf of ICICI Securities, I welcome you all on the Q1 FY25 Earnings Conference Call of Hester Biosciences and I thank the Hester Biosciencesâ Management Team for giving us this opportunity to host this call. Today on this call, we have with us, Mr. Rajiv Gandhi, CEO and Managing Director; Ms. Priya Gandhi, Executive Director; and Mr. Nikhil Jhanwar, CFO. I will now hand over the call to the Hester Management Team for their opening remarks. Thank you.
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
